About Neuromod Devices
Neuromod Devices is a Healthcare company based in Dublin (Ireland) founded in 2010 by Ross O'Neill. Neuromodulation treatments for tinnitus are provided using bi-modal technology. Neuromod Devices has raised $54.59 million across 9 funding rounds from investors including SVB, European Investment Bank and Kreos Capital. Its chief executive, as recorded, is Ross O'Neill. Neuromod Devices offers products and services including Lenire. Its focus areas include Life Sciences, ENT Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Neuromod Devices Limited. Its competitors include Lenire and MuteButton; 1 of its 2 listed competitors has raised funding.
Company details
The company was founded in 2010 in Dublin, Ireland, within the medical devices sector focused on neuromodulation. Treatments for chronic tinnitus and other neurological disorders are delivered through an intra-oral device, Bluetooth headphones, and sound-tongue stimulating systems. Patented bi-modal technology is applied to target these conditions, with operations centered in Europe.
- Headquarters Dublin, Ireland
- Founders Ross O'Neill
- SectorsHealthcare
- Website neuromoddevices.com
- Social LinkedIn X
- Legal Name Neuromod Devices Limited
- Total Equity Funding$54.59M (USD)
in 9 rounds
- Latest Funding Round$10.84M (USD), Series B
Mar 2025
- InvestorsSVB
& 6 more
Products & Services of Neuromod Devices
Neuromod Devices offers a comprehensive portfolio of products and services, including Lenire.
Bimodal neuromodulation device for tinnitus treatment at home.
Funding Insights of Neuromod Devices
Neuromod Devices has successfully raised a total of $54.59M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $10.84 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $54.59M
- Total Rounds 9
- Last Round Series B — $10.84M
- First Round $6.2M
(Sep 2015)
- Investors Count 7
All 9 funding rounds of Neuromod Devices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $10.84M | Series B | – | Fountain Healthcare Partners, Panakes Partners | – |
| Apr 2023 | $16.43M | Series B | – | Panakes Partners | |
| Apr 2023 | $16.43M | Debt – Venture | – | – | |
| Oct 2020 | Debt – Venture | – | – | ||
| Oct 2020 | $12.34M | Series B | – | Fountain Healthcare Partners | |
| Sep 2019 | $8.78M | Series A | – | Fountain Healthcare Partners, Moffett Investments | |
| Sep 2019 | Debt – Venture | – | – | ||
| Jun 2018 | Series A | – | – | ||
| Sep 2015 | $6.2M | Series A | – | – |
7 investors in total: 7 institutional.
Investors in Neuromod Devices
Neuromod Devices has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, European Investment Bank and Kreos Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Risk capital is provided to life sciences entrepreneurs. | fh-partners.com | Dublin, Ireland | ||
| panakes.it | ||||
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg | |
Venture debt is provided to growth-stage companies across multiple sectors. | 1998 | kreoscapital.com | London, United Kingdom | |
| moffettinvestments.tcc.mode | ||||
Early-stage centric life sciences focused VC firm funding in Netherlands, Belgium and the US | thujacapital.com | Utrecht, Netherlands | ||
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States |
Investor details for Neuromod Devices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neuromod Devices
26 people are tracked at Neuromod Devices (18 in leadership, 3 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Ross O'Neill | Founder & CEO | Leadership |
Brendan Conlon | Chief Medical Officer | Leadership |
Hubert Lim | Chief Scientific Officer | Leadership |
Florian Elsaesser | Chief Strategy & Corporate Development Officer | Leadership |
Derek Madden | Chief Financial Officer | Leadership |
Diarmuid Flavin | COO | Leadership |
Tish Ramirez | Chief Commercial Officer, Neuromod USA | Leadership |
Eric Timm | President, Global Commercial Operations & CEO, Neuromod USA | Leadership |
Stephanie Glowacki | CFO, Neuromod USA | Leadership |
Louise Hughes | Finance Director | Leadership |
Jakob Kümmel | Director Clinical Affairs | Leadership |
Fran Coogan | Director Of Quality And Regulatory Affairs | Leadership |
Aoife McNally | HR Director | Leadership |
Joe Roche | Head Of Communications | Leadership |
Daniel Collins | Head Of Marketing USA | Leadership |
Ciara Magee | Head Of Global Key Account Marketing And Global Marketing Operations | Leadership |
Neil Doyle | VP And Chief Marketing Officer | Leadership |
Matthew Foster | Design Director | Leadership |
Manus Rogan | Chairman | Board & advisors |
Susan Whichard | Non-Executive Board Member | Board & advisors |
6 more people are available in the full profile.
Complete people profiles for Neuromod Devices
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neuromod Devices
3 dated milestones of Neuromod Devices across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Neuromod Devices is founded.
- Funding First funding round of $6.2M.
- Funding Latest funding round, Series B, of $10.8M.
Competitors of Neuromod Devices
Neuromod Devices has 2 listed competitors in our database, 1 of them funded. They include Lenire and MuteButton.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lenire.com | 2010 | Dublin, Ireland | Offers medical device for tinnitus relief through sound and stimulation therapy. | |||
| mutebutton.ie | 2010 | Dublin, Ireland | $287,728 | Neuromodulation to treat tinnitus |
Detailed competitors of Neuromod Devices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neuromod Devices
Websites that share an audience with Neuromod Devices (neuromoddevices.com).
Websites whose visitors overlap most with Neuromod Devices. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
acufene.it | acufene.it | 100% | #1,185,574 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neuromod Devices
Complete news archive for Neuromod Devices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuromod Devices
Neuromod Devices was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Neuromod Devices is headquartered in Dublin, Ireland.
Ross O'Neill is the CEO of Neuromod Devices, as recorded in our data. They have also founded this company.
Neuromod Devices is a funded company, having raised a total of $54.59M across 9 funding rounds to date. The company's 1st funding round was a Series A of $6.2M, raised on Sep 2015.
The company was founded in 2010 in Dublin, Ireland, within the medical devices sector focused on neuromodulation. Treatments for chronic tinnitus and other neurological disorders are delivered through an intra-oral device, Bluetooth headphones, and sound-tongue stimulating systems. Patented bi-modal technology is applied to target these conditions, with operations centered in Europe.
Neuromod Devices's top competitors include MuteButton and Lenire.
Neuromod Devices offers Lenire.
Neuromod Devices has 7 investors. Key investors include SVB, European Investment Bank, Kreos Capital, Fountain Healthcare Partners, and Panakes Partners.
Neuromod Devices operates through Neuromod Devices Limited.